Xarelto is a new generation anti-coagulant (blood thinner) that is manufactured by Janssen Pharmaceutical and marketed by Bayer Healthcare. It is widely prescribed to prevent blood clots in patients with atrial fibrillation. The drug is also used to prevent deep vein thrombosis (blood clots in the deep veins, typically in the legs) and pulmonary embolism (blood clots in the lungs). Xarelto and other similar anti-coagulant drugs including Pradaxa, Eliquis, Zontivity and Savaysa are typically prescribed as an alternative to Coumadin (also known as Warfarin), which has been widely used since the mid-1950’s.
Coumadin is an effective blood thinner. In addition, the blood thinning effects of Coumadin can be reversed for patients with an emergent need such as emergency surgery. On the other hand, Xarelto can cause internal bleeding which cannot be reversed. It has been linked to severe and even fatal injuries caused by uncontrolled bleeding.
Xarelto has also been linked to infections associated with hip or knee replacement surgery, decreased hemoglobin, brain hemorrhaging, hematoma, peripheral edema, and difficulty breathing.
Contact Us for a Free Case Evaluation
Allen & Allen is currently investigating cases on behalf of injured Xarelto users. If you or one of your loved ones has experienced uncontrolled bleeding or another serious injury while using the prescription drug Xarelto, contact Allen & Allen online or by calling 1-866-388-1307.
About The Author: Jason Konvicka is a partner and trial attorney with Allen & Allen in Richmond, Virginia. During his 20+ year career, he has achieved numerous record-setting jury verdicts and substantial settlements on behalf of his clients. His practice focuses on medical malpractice, bus accidents and product liability personal injury cases. Outside of the courtroom, Jason is involved with the Virginia Trial Lawyers Association and currently serves on its Board of Governors as Vice President.